Your challenge: You are facing ever-increasing competition for your Oncology product
Commercial success with an Oncology drug is becoming more difficult as more players enter the market.
Are you:
- formulating the right messages and promotional mix in a promotionally less sensitive market, across multiple treatment lines and target audiences?
- trying to understand the different drivers across treatment lines, therapy segments, hospital segments, or physician segments?
- segmenting across different geographic markets with different target audiences?
- handling multiple brands focused on the same indication and need to ensure maximum overall success for the company by balancing the promotion of these correctly?
- handling one brand focused on multiple indications and segments and need to get the promotional balance correct for maximum return?
Our solution
94.8 Analytics is a powerful tool in the Oncology marketing arsenal, offering deep robust data and the ability to war-game competitive scenarios for best yield on investment.
You’ll know:
- the key driver channels by doctor segment, and indication, and line of treatment
- what is really influencing prescribers to continue or change prescribing behavior
- how to allocate resources across channels, across segments, across lines of treatment, across indications, across brands and even across countries for maximal return
- the core changes needed to accelerate growth for your brand
- where the best market opportunities lie and how to access them
94.8 will evaluate your competitors and market segments and identifies what market opportunities are open to you and how to take advantage of these to grow your revenue and profit by a specific amount.
You can even input your budget into specific areas and immediately see the impact these changes will have on your sales and your competitor’s sales. Whether you are focusing on a broad range of cancer or a specific sub population, our 94.8 Analytics can help you achieve your growth objectives.